公开(公告)号：EP3861982A3

公开(公告)日：2021-09-01

申请号：EP20208058.6

申请日：2014-12-05

申请人： ALLERGAN, INC.

发明人： Maynor, Benjamin ,  Garcia, Andres ,  Das, Sanjib Kumar ,  Navratil, Tomas ,  Yerxa, Benjamin Robinson ,  Tully, Janet

IPC分类号： A61K9/00 ,  A61K47/34 ,  A61K31/5575 ,  A61P27/06 ,  A61P27/02

摘要： The present invention relates to a pharmaceutical composition for treating an ocular condition, comprising a biodegradable polymer matrix and at least one therapeutic agent homogenously dispersed within the polymer matrix. The composition can be in the form of an ocular implant.

公开(公告)号：EP3861982A2

公开(公告)日：2021-08-11

申请号：EP20208058.6

申请日：2014-12-05

申请人： ALLERGAN, INC.

发明人： Maynor, Benjamin ,  Garcia, Andres ,  Das, Sanjib Kumar ,  Navratil, Tomas ,  Yerxa, Benjamin Robinson ,  Tully, Janet

IPC分类号： A61K9/00 ,  A61K47/34 ,  A61K31/5575 ,  A61P27/06 ,  A61P27/02

摘要： The present invention relates to a pharmaceutical composition for treating an ocular condition, comprising a biodegradable polymer matrix and at least one therapeutic agent homogenously dispersed within the polymer matrix. The composition can be in the form of an ocular implant.